JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s

In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a significant benefit. This short blog is just the headlines. We will follow up with a more in depth analysis in the next few days/weeks (with … Continue reading JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s